Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Cash & Current Investments (2020 - 2025)

Rapid Micro Biosystems' Cash & Current Investments history spans 6 years, with the latest figure at $22.4 million for Q3 2025.

  • For Q3 2025, Cash & Current Investments fell 63.17% year-over-year to $22.4 million; the TTM value through Sep 2025 reached $22.4 million, down 63.17%, while the annual FY2024 figure was $50.7 million, 44.89% down from the prior year.
  • Cash & Current Investments for Q3 2025 was $22.4 million at Rapid Micro Biosystems, up from $13.1 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $219.6 million in Q3 2021 and bottomed at $100000.0 in Q1 2025.
  • The 5-year median for Cash & Current Investments is $65.9 million (2022), against an average of $73.9 million.
  • The largest annual shift saw Cash & Current Investments soared 20177.33% in 2024 before it plummeted 99.87% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $193.5 million in 2021, then plummeted by 43.85% to $108.6 million in 2022, then dropped by 15.27% to $92.1 million in 2023, then plummeted by 44.89% to $50.7 million in 2024, then plummeted by 55.84% to $22.4 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Cash & Current Investments are $22.4 million (Q3 2025), $13.1 million (Q2 2025), and $100000.0 (Q1 2025).